GEODE CAPITAL MANAGEMENT, LLC - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 17 filers reported holding AC IMMUNE SA in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AC IMMUNE SA
ValueSharesWeighting
Q2 2024$218,640
+34.8%
54,7970.0%0.00%
Q1 2024$162,199
-20.7%
54,797
+33.9%
0.00%
Q4 2023$204,570
+75.4%
40,9140.0%0.00%
Q3 2023$116,604
+6.3%
40,914
+10.2%
0.00%
Q2 2023$109,683
+26.3%
37,1180.0%0.00%
Q1 2023$86,856
+115708.0%
37,1180.0%0.00%
Q4 2022$75
-99.9%
37,1180.0%0.00%
Q3 2022$117,000
-12.0%
37,1180.0%0.00%
Q2 2022$133,000
-10.1%
37,1180.0%0.00%
Q1 2022$148,000
-19.1%
37,1180.0%0.00%
Q4 2021$183,000
-26.5%
37,1180.0%0.00%
Q3 2021$249,000
-15.3%
37,1180.0%0.00%
Q2 2021$294,000
+9.3%
37,118
+4.7%
0.00%
Q1 2021$269,000
+124.2%
35,468
+52.1%
0.00%
Q4 2020$120,000
-44.4%
23,325
-47.4%
0.00%
Q3 2020$216,000
-20.0%
44,330
+10.2%
0.00%
Q2 2020$270,000
-9.1%
40,225
-6.6%
0.00%
Q1 2020$297,000
-46.0%
43,086
-33.3%
0.00%
Q4 2019$550,000
+110.7%
64,598
+22.1%
0.00%
Q3 2019$261,000
-11.8%
52,916
-0.9%
0.00%
Q2 2019$296,000
+10.4%
53,412
+0.5%
0.00%
Q1 2019$268,000
-72.8%
53,164
-49.1%
0.00%
Q4 2018$986,000
+130.9%
104,468
+95.3%
0.00%
Q3 2018$427,000
-10.7%
53,495
+4.0%
0.00%
Q2 2018$478,000
+2.4%
51,448
+13.9%
0.00%
Q1 2018$467,000
-17.2%
45,188
+2.5%
0.00%
Q4 2017$564,000
+16.5%
44,068
+2.8%
0.00%
Q3 2017$484,000
+112.3%
42,852
+65.1%
0.00%
Q2 2017$228,000
-32.3%
25,953
-20.2%
0.00%
Q1 2017$337,000
+2.4%
32,536
+28.2%
0.00%
Q4 2016$329,000
-6.0%
25,384
+19.2%
0.00%
Q3 2016$350,00021,2900.00%
Other shareholders
AC IMMUNE SA shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 9,819,434$54,498,0005.95%
Prosight Management, LP 563,900$3,130,0001.58%
Artal Group S.A. 1,000,000$5,550,0000.22%
Temasek Holdings (Private) Ltd 2,614,095$14,508,0000.10%
BOOTHBAY FUND MANAGEMENT, LLC 111,754$620,0000.06%
COHEN LAWRENCE B 13,350$74,0000.05%
Tekla Capital Management LLC 171,813$954,0000.04%
Athanor Capital, LP 42,100$234,0000.03%
APPLETON PARTNERS INC/MA 15,360$85,0000.01%
A.R.T. Advisors, LLC 30,985$172,0000.01%
View complete list of AC IMMUNE SA shareholders